AP
HOLX

Atwood & Palmer’s Hologic HOLX Stock Holding History

Atwood & Palmer’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-219
Closed -$14.3K – 511
2025
Q2 		$14.3K Sell
219
-353,126
-100% -$21.2M ﹤0.01% 350
2025
Q1 		$21.8M Sell
353,345
-4,390
-1% -$291K 1.51% 32
2024
Q4 		$25.8M Buy
357,735
+1,714
+0.5% +$134K 1.77% 23
2024
Q3 		$29M Buy
356,021
+1,686
+0.5% +$135K 1.97% 20
2024
Q2 		$26.3M Buy
354,335
+5,008
+1% +$375K 1.99% 19
2024
Q1 		$27.2M Buy
349,327
+8,007
+2% +$596K 2.07% 18
2023
Q4 		$24.4M Sell
341,320
-2,135
-0.6% -$149K 1.97% 21
2023
Q3 		$23.8M Buy
343,455
+822
+0.2% +$62.1K 2.09% 19
2023
Q2 		$27.7M Buy
342,633
+4,901
+1% +$401K 2.48% 11
2023
Q1 		$27.3M Buy
337,732
+787
+0.2% +$63.4K 2.56% 10
2022
Q4 		$25.2M Buy
336,945
+4,975
+1% +$354K 2.28% 11
2022
Q3 		$21.4M Buy
331,970
+3,450
+1% +$239K 2.12% 14
2022
Q2 		$22.8M Buy
328,520
+1,144
+0.3% +$84.9K 2.22% 14
2022
Q1 		$25.1M Buy
327,376
+2,740
+0.8% +$197K 2.17% 18
2021
Q4 		$24.9M Buy
324,636
+3,279
+1% +$241K 2.08% 19
2021
Q3 		$23.7M Sell
321,357
-731
-0.2% -$54.8K 2.12% 16
2021
Q2 		$21.5M Buy
322,088
+8,323
+3% +$556K 1.93% 18
2021
Q1 		$23.3M Buy
313,765
+5,687
+2% +$432K 2.25% 15
2020
Q4 		$22.4M Sell
308,078
-1,825
-0.6% -$129K 2.41% 14
2020
Q3 		$20.6M Buy
309,903
+1,400
+0.5% +$88.6K 2.59% 11
2020
Q2 		$17.6M Buy
308,503
+1,550
+0.5% +$76.1K 2.38% 16
2020
Q1 		$10.8M Buy
306,953
+102,087
+50% +$4.86M 1.69% 23
2019
Q4 		$10.7M Sell
204,866
-7,150
-3% -$356K 1.37% 27
2019
Q3 		$10.7M Buy
212,016
+1,591
+0.8% +$78.3K 1.44% 27
2019
Q2 		$10.1M Buy
+210,425
New +$9.73M 1.36% 27

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Atwood & Palmer's HOLX Position: Q3 2025 in Review

Atwood & Palmer sold out of Hologic (HOLX) in Q3 2025, closing a stake of 219 shares — an estimated $14.3K sold.

Atwood & Palmer first reported a position in HOLX in Q2 2019 and held it in 25 quarters. The position peaked at $29M in Q3 2024. 738 funds tracked by Wall St. Rank hold HOLX as of Q3 2025.

  • Atwood & Palmer reported no remaining Hologic position as of Q3 2025 after selling out during the quarter.
  • Atwood & Palmer sold 219 Hologic shares in Q3 2025, an estimated $14.3K.
  • Atwood & Palmer first reported a position in Hologic in Q2 2019 and held it in 25 quarters.
  • Atwood & Palmer's Hologic position peaked at $29M in Q3 2024.
  • 738 funds tracked by Wall St. Rank held Hologic as of Q3 2025.

Based on Atwood & Palmer's 13F filing for Q3 2025, filed 15 Oct 2025.